SEC Form 4 · accession 0001104659-15-023039
Larimar Therapeutics, Inc. · LRMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Atlas Venture Fund VII L P
10% Owner
Atlas Venture Associates VII, Inc.
10% Owner
Atlas Venture Associates VII, L.P.
10% Owner
Period of report
Mar 24, 2015
Accepted (ET)
Mar 26, 2015 · 2:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374690
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 24, 2015 | J | 1,000,000 | $0.00 | D | 4,632,730 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On March 24, 2015, Atlas Venture Fund VII LP ("Atlas Venture") distributed in-kind, without consideration, all 1,000,000 shares of the Issuer's Common Stock, pro-rata, to its limited partners.
- F2These shares were held directly by Atlas Venture. The general partner of Atlas Venture is Atlas Venture Associates VII, L.P. ("AVA VII LP"), and the general partner of AVA VII LP is Atlas Venture Associates VII, Inc. ("AVA VII Inc."). AVA VII LP and AVA VII Inc. disclaim beneficial ownership of such shares, except to the extent of a pecuniary interest, if any, therein.